Výsledky vyhledávání - Herman Nilsson‐Ehle
- Zobrazuji výsledky 1 - 13 z 13
-
1
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin... Autor Catharina Lewerin, Michael Matousek, Gunilla Steen, Boo Johansson, Bertil Steen, Herman Nilsson‐Ehle
Vydáno 2005Artigo -
2
The number of tumour‐infiltrating TIA‐1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B‐cell lymphoma Autor Sverker Hasselblom, Margrét Sigurðadóttir, Ulrika Hansson, Herman Nilsson‐Ehle, Börje Ridell, Per‐Ola Andersson
Vydáno 2007Artigo -
3
Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study Autor Sara Ekberg, Karin E. Smedby, Ingrid Glimelius, Herman Nilsson‐Ehle, Christina Goldkuhl, Catharina Lewerin, Mats Jerkeman, Sandra Eloranta
Vydáno 2020Artigo -
4
Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study Autor Tarec Christoffer El‐Galaly, Lasse Hjort Jakobsen, Martin Hutchings, Peter de Nully Brown, Herman Nilsson‐Ehle, Elisabeth Székely, Karen Juul Mylam, Viktoria Hjalmar, Hans Erik Johnsen, Martin Bøgsted, Mats Jerkeman
Vydáno 2015Artigo -
5
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study Autor Anna Abrahamsson, Alexandra Albertsson‐Lindblad, Peter de Nully Brown, Stefanie Baumgartner-Wennerholm, Lars Møller Pedersen, Francesco d’Amore, Herman Nilsson‐Ehle, Paw Jensen, Michael Pedersen, Christian H. Geisler, Mats Jerkeman
Vydáno 2014Artigo -
6
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression Autor John F. Seymour, Robert Marcus, Andrew Davies, Eve Gallop‐Evans, Andrew Grigg, Andrew Haynes, Michael Herold, Thomas Illmer, Herman Nilsson‐Ehle, Martin Sökler, Ulrich Dünzinger, Tina Nielsen, Aino Launonen, Wolfgang Hiddemann
Vydáno 2018Artigo -
7
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma Autor Niels Smedegaard Andersen, Lone Bredo Pedersen, Anna Laurell, Erkki Elonen, Arne Kolstad, Anne Marie Boesen, Lars Møller Pedersen, Grete F. Lauritzsen, Roald Ekanger, Herman Nilsson‐Ehle, Marie Nordström, Susanne Fredén, Mats Jerkeman, Mikael Eriksson, Jaan Väärt, Beatrice Malmer, Christian H. Geisler
Vydáno 2009Artigo -
8
Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of... Autor Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin, Magnus Carlsson, Jan Carneskog, Inger Marie S. Dahl, Ingunn Dybedal, Gunnar Grimfors, Lena Kanter‐Lewensohn, Olle Linder, Michaela Luthman, Eva Löfvenberg, Herman Nilsson‐Ehle, Jan Samuelsson, Jon‐Magnus Tangen, Ingemar Winqvist, G Öberg, Anders Österborg, Åke Öst
Vydáno 1998Artigo -
9
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter... Autor Christian H. Geisler, Arne Kolstad, Anna Laurell, Niels Smedegaard Andersen, Lone Bredo Pedersen, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson‐Ehle, Elisabeth Ralfkiær, Måns Åkerman, Mats Ehinger, Christer Sundström, Ruth Langholm, Jan Delabie, Marja‐Liisa Karjalainen‐Lindsberg, Peter de Nully Brown, Erkki Elonen
Vydáno 2008Artigo -
10
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2... Autor Arne Kolstad, Lone Bredo Pedersen, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter de Nully Brown, Eva Kimby, Hans Bentzen, Christer Sundström, Mats Ehinger, Marja‐Liisa Karjalainen‐Lindsberg, Jan Delabie, Elisabeth Ralfkiær, Unn‐Merete Fagerli, Herman Nilsson‐Ehle, Grete F. Lauritzsen, Outi Kuittinen, Carsten Utoft Niemann, Christian H. Geisler
Vydáno 2016Artigo -
11
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma Autor Arne Kolstad, Anna Laurell, Mats Jerkeman, Kirsten Grønbæk, Erkki Elonen, Riikka Räty, Lone Bredo Pedersen, Annika Loft, Trond Velde Bogsrud, Eva Kimby, Per Boye Hansen, Unn-Merete Fagerli, Herman Nilsson‐Ehle, Grete F. Lauritzsen, Anne Kristine Lehmann, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Elisabeth Ralfkiær, Mats Ehinger, Jan Delabie, Hans Bentzen, Jukka Schildt, Kamelia Kostova-Aherdan, Henrik Frederiksen, Peter de Nully Brown, Christian H. Geisler
Vydáno 2014Artigo -
12
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (<scp>MCL</scp>2): prolonged remissions without survival plateau Autor Christian Winther Eskelund, Arne Kolstad, Mats Jerkeman, Riikka Räty, Anna Laurell, Sandra Eloranta, Karin E. Smedby, Simon Husby, Lone Bredo Pedersen, Niels Smedegaard Andersen, Mikael Eriksson, Eva Kimby, Hans Bentzen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson‐Ehle, Elisabeth Ralfkiær, Mats Ehinger, Christer Sundström, Jan Delabie, Marja‐Liisa Karjalainen‐Lindsberg, Christopher T. Workman, Christian Garde, Erkki Elonen, Peter de Nully Brown, Kirsten Grønbæk, Christian H. Geisler
Vydáno 2016Artigo -
13
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial Autor Judith Trotman, Sally F. Barrington, David Belada, Michel Meignan, Robert MacEwan, Carolyn Owen, Václav Ptáčník, András Rosta, Günter Fingerle‐Rowson, Jiawen Zhu, Tina Nielsen, Deniz Şahin, Wolfgang Hiddemann, Robert Marcus, Andrew Davies, Mark Hertzberg, Andrew Grigg, Paul Cannell, Hang Quach, Stephen Opat, Constantine S. Tam, Paula Marlton, Ann Janssens, Fritz Offner, Koen Van Eygen, Randeep Sangha, Pam McKay, Jonathan Wilson, Richard van der Jagt, Daryl Roitman, Marek Trněný, Jiřı́ Mayer, Katell Le Dû, Philippe Solal‐Céligny, Guillaume Cartron, Charles Foussard, Norbert Frickhofen, Peter Schmidt, Ullrich Graeven, Tobias Gaska, Rudolf Schlag, Martin Sökler, Gabriele Prange‐Krex, Axel Florschütz, Hans‐Walter Lindemann, Christoph Schimmelpfennig, Solveig Tonndorf, Mathias Hänel, Georg Heß, Enrico Schalk, Heiko Hütten, Gottfried Doelken, Michael Pfreundschuh, Ulrich Keller, Michael Herold, Roswitha Forstpointner, Ursula Vehling‐Kaiser, Martin Hoffmann, Zita Borbényi, M. Udvardy, Judit Demeter, Alessandro Rambaldi, Enrica Morra, Federico Massimo, Ignazio Majolino, Monica Balzarotti, Gianpietro Semenzato, Miguel Canales, Francisco Javier Peñalver Párraga, Alfonso Soler Campos, Juan‐Manuel Sancho, José Antonio Márquez Navarro, Carlos Grande García, Herman Nilsson‐Ehle, Helen O. McCarthy, Chris Pocock, Shalal Sadullah, Ram Malladi, John Radford, Ed Kanfer, Anton Kruger, Dominic Culligan, Martin J.S. Dyer, Ruth Pettengell, John Seymour, John G. Gribben, Saad Al‐Ismail, F. N. Al‐Refaie, Norbert Blesing, Christopher Macnamara, Ann O’Callaghan, Andrew Haynes, George Follows, Roderick J. Johnson, David Cunningham, Kristian M. Bowles, Graham P. Collins, Eve Gallop‐Evans, Stephen Robinson, Chezhian Subash
Vydáno 2018Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Lymphoma
Oncology
Surgery
Gastroenterology
Mantle cell lymphoma
Chemotherapy
Rituximab
Transplantation
Autologous stem-cell transplantation
Bone marrow
Clinical trial
Biology
Confidence interval
Cyclophosphamide
Cytarabine
Diffuse large B-cell lymphoma
Environmental health
Follicular lymphoma
Immunology
International Prognostic Index
Minimal residual disease
Obinutuzumab
Population
Randomized controlled trial
Vincristine
Alternative medicine
Anemia
Antibody